Prezista label
Interaction Color Code
Clinical Bottom Line
Do not coadminister: Potential for increased levels of ergotamine
Drug 1
Drug 2
Clinical Effects
Potential for increased risk of ergotamine adverse effects (e.g. peripheral vasospasm, ischemia)
Management
Contraindicated. Use alternative agents.
Alternative Agents
5-HT agonists ("triptans")
Import ID
937
